» Articles » PMID: 27842510

MiR-124-3p Functions As a Tumor Suppressor in Breast Cancer by Targeting CBL

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2016 Nov 16
PMID 27842510
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The origin and development of breast cancer remain complex and obscure. Recently, microRNA (miRNA) has been identified as an important regulator of the initiation and progression of breast cancer, and some studies have shown the essential role of miR-124-3p as a tumor suppressor in breast tumorigenesis. However, the detailed role of miR-124-3p in breast cancer remains poorly understood.

Methods: Quantitative RT-PCR and western blotting assays were used to measure miR-124-3p and CBL expression levels in breast cancer tissues, respectively. Luciferase reporter assay was employed to validate the direct targeting of CBL by miR-124-3p. Cell proliferation and invasion assays were performed to analyze the biological functions of miR-124-3p and CBL in breast cancer cells.

Results: In the present study, we found that miR-124-3p was consistently downregulated in breast cancer tissues. Moreover, we showed that miR-124-3p significantly suppressed the proliferation and invasion of breast cancer cells. In addition, we investigated the molecular mechanism through which miR-124-3p contributes to breast cancer tumorigenesis and identified CBL (Cbl proto-oncogene, E3 ubiquitin protein ligase) as a direct target gene of miR-124-3p. Moreover, we found that ectopic expression of CBL can attenuate the inhibitory effect of miR-124-3p on cell proliferation and invasion in breast cancer cells.

Conclusions: This study identified a new regulatory axis in which miR-124-3p and CBL regulate the proliferation and invasion of breast cancer cells.

Citing Articles

miR-124-3p inhibits CRC proliferation, migration, and invasion by targeting ITGB1.

Li J, Liu L Discov Oncol. 2025; 16(1):158.

PMID: 39934532 PMC: 11813836. DOI: 10.1007/s12672-025-01936-2.


Evaluation of tumorigenesis-related miRNAs in breast cancer in Egyptian women: a retrospective, exploratory analysis.

Salum G, Elaraby N, Ahmed H, Abd El Meguid M, Fotouh B, Ashraf M Sci Rep. 2024; 14(1):29757.

PMID: 39614097 PMC: 11607072. DOI: 10.1038/s41598-024-68758-0.


MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties.

Zhang Q, Yu M, Yang L, Sun D Heliyon. 2024; 10(18):e37771.

PMID: 39381215 PMC: 11459020. DOI: 10.1016/j.heliyon.2024.e37771.


The Role of MicroRNA-124-3p in Breast Cancer Stem Cell Inhibition by Benzyl Isothiocyanate.

Kim S, Singh S Pharm Res. 2024; 41(10):1921-1932.

PMID: 39375243 PMC: 11792746. DOI: 10.1007/s11095-024-03775-2.


miR-124-3p downregulates EGR1 to suppress ischemia-hypoxia reperfusion injury in human iPS cell-derived cardiomyocytes.

Yang Q, Murata K, Ikeda T, Minatoya K, Masumoto H Sci Rep. 2024; 14(1):14811.

PMID: 38926457 PMC: 11208498. DOI: 10.1038/s41598-024-65373-x.


References
1.
Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

2.
John B, Enright A, Aravin A, Tuschl T, Sander C, Marks D . Human MicroRNA targets. PLoS Biol. 2004; 2(11):e363. PMC: 521178. DOI: 10.1371/journal.pbio.0020363. View

3.
Lee H, Tsygankov A . c-Cbl regulates glioma invasion through matrix metalloproteinase 2. J Cell Biochem. 2010; 111(5):1169-78. DOI: 10.1002/jcb.22839. View

4.
Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link K . UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. Leukemia. 2015; 30(3):728-39. PMC: 4775400. DOI: 10.1038/leu.2015.275. View

5.
Andorfer C, Necela B, Thompson E, Perez E . MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol Med. 2011; 17(6):313-9. DOI: 10.1016/j.molmed.2011.01.006. View